S&CO Inc. Sells 54,363 Shares of Cameco Corporation $CCJ

S&CO Inc. trimmed its stake in shares of Cameco Corporation (NYSE:CCJ) (TSE:CCO) by 9.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 517,471 shares of the basic materials company’s stock after selling 54,363 shares during the quarter. Cameco makes up about 2.7% of S&CO Inc.’s portfolio, making the stock its 9th largest holding. S&CO Inc. owned about 0.12% of Cameco worth $43,395,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in CCJ. Midwest Trust Co bought a new stake in Cameco during the 3rd quarter worth $202,000. Wealthfront Advisers LLC raised its holdings in Cameco by 11.8% during the 3rd quarter. Wealthfront Advisers LLC now owns 5,131 shares of the basic materials company’s stock worth $430,000 after purchasing an additional 543 shares during the last quarter. Navellier & Associates Inc. acquired a new position in shares of Cameco in the 3rd quarter worth approximately $666,000. Means Investment CO. Inc. bought a new stake in shares of Cameco in the 3rd quarter valued at $1,117,000. Finally, CloudAlpha Capital Management Limited Hong Kong acquired a new stake in shares of Cameco during the third quarter worth $1,226,000. Institutional investors and hedge funds own 70.21% of the company’s stock.

Cameco Trading Up 6.2%

NYSE CCJ opened at $120.69 on Tuesday. The company has a quick ratio of 1.85, a current ratio of 2.99 and a debt-to-equity ratio of 0.15. Cameco Corporation has a 52 week low of $35.00 and a 52 week high of $135.24. The business has a 50 day moving average price of $104.36 and a 200-day moving average price of $90.98. The company has a market cap of $52.56 billion, a price-to-earnings ratio of 140.34 and a beta of 0.99.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Scotiabank reiterated an “outperform” rating on shares of Cameco in a report on Wednesday, October 29th. Glj Research reiterated a “buy” rating and issued a $99.74 target price on shares of Cameco in a report on Wednesday, December 3rd. The Goldman Sachs Group reissued a “buy” rating and issued a $131.00 price target on shares of Cameco in a research note on Wednesday, February 4th. Royal Bank Of Canada cut their price target on Cameco from $160.00 to $150.00 and set an “outperform” rating on the stock in a report on Thursday, November 13th. Finally, Raymond James Financial reiterated an “outperform” rating on shares of Cameco in a research note on Wednesday, January 14th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $131.39.

About Cameco

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.